documents

Regulatory documents from Regulations.gov including rules, proposed rules, notices, and supporting materials.

Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API

5 rows where agency_id = "FDA" and docket_id = "FDA-2003-P-0408" sorted by posted_date descending

✎ View and edit SQL

This data as json, CSV (advanced)

Suggested facets: subtype, posted_date, posted_month, comment_start_date, posted_date (date), comment_start_date (date), comment_end_date (date), last_modified (date)

posted_year 2

document_type 2

agency_id 1

id agency_id docket_id title document_type subtype posted_date ▲ posted_year posted_month comment_start_date comment_end_date last_modified fr_doc_num open_for_comment withdrawn object_id
FDA-2003-P-0408-0005 FDA to request the commissioner of Food and Drugs to determine that Lovenox(enoxaparin sodlium),NDA 20-164(90mg/0.6ml)Product Number 006),sponsored by Aventis Pharmaceuticals Inc.(Aventis), was not withdrawn from sale for reasons of safety of effectiveness. FDA-2003-P-0408 Letter from FDA CDER to Olsson, Frank and Weeda, PC Other LET-Letter 2004-03-11T05:00:00Z 2004 3 2004-03-08T05:00:00Z   2024-10-22T21:03:34Z   0 0 09000064804a1b0a
FDA-2003-P-0408-0004 FDA to request the commissioner of Food and Drugs to determine that Lovenox(enoxaparin sodlium),NDA 20-164(90mg/0.6ml)Product Number 006),sponsored by Aventis Pharmaceuticals Inc.(Aventis), was not withdrawn from sale for reasons of safety of effectiveness. FDA-2003-P-0408 FDA Notice of Determination Notice N-Notice 2004-03-08T05:00:00Z 2004 3 2004-03-05T05:00:00Z 2004-03-09T04:59:59Z 2024-10-22T20:51:07Z 69FR10711 0 0 09000064804a1b09
FDA-2003-P-0408-0003 FDA to request the commissioner of Food and Drugs to determine that Lovenox(enoxaparin sodlium),NDA 20-164(90mg/0.6ml)Product Number 006),sponsored by Aventis Pharmaceuticals Inc.(Aventis), was not withdrawn from sale for reasons of safety of effectiveness. FDA-2003-P-0408 Letter from FDA CDER to Olsson, Frank and Weeda, P.C. Other LET-Letter 2003-12-09T05:00:00Z 2003 12 2003-11-24T05:00:00Z   2024-10-22T21:03:14Z   0 0 09000064804a1b08
FDA-2003-P-0408-0001 FDA to request the commissioner of Food and Drugs to determine that Lovenox(enoxaparin sodlium),NDA 20-164(90mg/0.6ml)Product Number 006),sponsored by Aventis Pharmaceuticals Inc.(Aventis), was not withdrawn from sale for reasons of safety of effectiveness. FDA-2003-P-0408 Acknowledgment Letter from FDA DMB to Olsson, Frank and Weeda, P.C. Other Acknowledgement Letter/Receipt 2003-06-11T04:00:00Z 2003 6 2003-06-11T04:00:00Z   2024-10-22T20:37:10Z   0 0 09000064804a1afe
FDA-2003-P-0408-0002 FDA to request the commissioner of Food and Drugs to determine that Lovenox(enoxaparin sodlium),NDA 20-164(90mg/0.6ml)Product Number 006),sponsored by Aventis Pharmaceuticals Inc.(Aventis), was not withdrawn from sale for reasons of safety of effectiveness. FDA-2003-P-0408 Unsigned Acknowledgment Letter from FDA DMB to Olsson, Frank and Weeda, P.C. Other Acknowledgement Letter/Receipt 2003-06-11T04:00:00Z 2003 6 2003-06-11T04:00:00Z   2024-10-22T20:40:51Z   0 0 09000064804a1b07

Advanced export

JSON shape: default, array, newline-delimited, object

CSV options: 

CREATE TABLE documents (
    id TEXT PRIMARY KEY,
    agency_id TEXT,
    docket_id TEXT REFERENCES dockets(id),
    title TEXT,
    document_type TEXT,
    subtype TEXT,
    posted_date TEXT,
    posted_year INTEGER,
    posted_month INTEGER,
    comment_start_date TEXT,
    comment_end_date TEXT,
    last_modified TEXT,
    fr_doc_num TEXT,
    open_for_comment INTEGER,
    withdrawn INTEGER,
    object_id TEXT
);
CREATE INDEX idx_docs_agency ON documents(agency_id);
CREATE INDEX idx_docs_docket ON documents(docket_id);
CREATE INDEX idx_docs_date ON documents(posted_date);
CREATE INDEX idx_docs_year ON documents(posted_year);
CREATE INDEX idx_docs_type ON documents(document_type);
CREATE INDEX idx_docs_frnum ON documents(fr_doc_num);